by thaan thaan | May 21, 2024
Dr. Daniel J. Burge is Senior Vice President, Clinical Development of Evommune. Dan joins Evommune from a consulting practice where he provided strategic advice and tactical implementation for clinical development of small molecules and biologics for biotechnology and...
by thaan thaan | Mar 14, 2024
Sam Chi serves as Vice President, Commercial and Portfolio Planning at Evommune. He is a seasoned commercial leader with over 20 years track record of success in various biopharma commercial roles spanning a wide range of therapeutic areas (immunology, hematology,...
by thaan thaan | Dec 14, 2023
Dr. Lorena Riol Blanco has deep biotech experience in translational research, pharmacology, drug discovery and development with a strong record of scientific leadership. Prior to Evommune, Lorena served as Director of Immunology/Immuno-Oncology at 23andMe where she...
by evommune | Dec 4, 2023
Luis Peña is Founder, President & Chief Executive Officer and a member of the Board of Directors of Evommune. Luis has more than 30 years of biotech and pharmaceutical experience with a proven track record of success in the global development of diverse products...
by evommune | Dec 4, 2023
Dr. Eugene A. Bauer is Chief Medical Officer and a member of the Board of Directors of Evommune. From 2010 to 2020, Gene was Founder, Chief Medical Officer, and member of the Board of Directors of Dermira, a clinical stage dermatology company acquired by Eli Lilly and...
